The Solution

The Solution

The Artilysin® Platform Technology

Artilysin®s fulfil all criteria to be the leading antimicrobial technology in a post antibiotic era.

Antibiotics vs. Artilysin®

Resistance

Artilysin®s were tested for the potential to provoke bacterial resistance in different bacterial species but up to now no resistance development has been observed.

There are several reasons why Artilysin®s exhibit a very low potential to induce resistance in bacteria:

  1. Artilysin®s represent a fast and innovative mechanism independent of any metabolic activity.
  2. Artilysin®s are of proteinaceous and biodegradable nature and do not accumulate in the environment.
  3. Artilysin®s have a high specificity and reduce the selective pressure on commensal flora.
  4. Artilysin® target a highly conserved cell wall component that can hardly be modified by bacteria.

Persistence

Persister cells play a pivotal role in chronic or reoccurring infections and are an important component in bacterial biofilms. In both situations, Artilysin®s represent a proper solution.

The innovative mode of action is independent of an active cell metabolism. This advantage enables Artilysin®s to kill persisters in contrast to antibiotics. Artilysin®s destabilise the cell wall and the targeted bacterium bursts within seconds due to the high osmotic pressure.

Microbiome

Artilysin®s preserve the natural microbiome. This has two consequences. The chance for long-time side-effects is considerably reduced. Additionally, Artilysin®s do not attack other bacteria and thus allows the microbiome to support the immune system and the natural healing process.

Copyright 2017 Lysando AG. All Rights Reserved.
We use cookies to enhance your experience. For more information about Cookies click here
Got it!